Showing results (461-470 of 513) with videos related to

Sort By:
Pageof 52
Elife|November 8, 2024
Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancerNayoung Kim, Sehhoon Park, Areum Jo, et al.
Cancers|October 28, 2023
A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)Yvonne L E Ang, Xiaotian Zhao, Thanyanan Reungwetwattana, et al.
International Journal of Radiation Oncology, Biology, Physics|August 16, 2005
An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomachSung Kim, Do Hoon Lim, Jeeyun Lee, et al.
Journal of Neuro-Oncology|November 6, 2010
Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trialIl Han Kim, Chul-Kee Park, Dae Seog Heo, et al.
JTO Clinical and Research Reports|June 29, 2026
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, <i>EGFR</i> Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY TrialNicolas Girard, Jonathan Goldman, Shun Lu, et al.
Nature Communications|May 10, 2020
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinomaNayoung Kim, Hong Kwan Kim, Kyungjong Lee, et al.
Genome Research|September 15, 2012
The transcriptional landscape and mutational profile of lung adenocarcinomaJeong-Sun Seo, Young Seok Ju, Won-Chul Lee, et al.
Eclinicalmedicine|June 17, 2025
Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trialJhingook Kim, Yeong Hak Bang, Sehhoon Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2022
Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLCHyun Ae Jung, Jinyeong Lim, Yoon-La Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2024
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722Tony Mok, Kazuhiko Nakagawa, Keunchil Park, et al.
Pageof 52